English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Latest Press Releases
Tuesday, December 12, 2023
DATE KSA: Uniting Tech Pioneers for Saudi Arabia's Digital Transformation
23:40 HKT/SGT
Acrometa Signs Strategic Cooperation Framework Agreement to Develop Co-Working Lab Space in China
22:20 HKT/SGT
Nearpay Raises $14M in Series "A" Round Led by Sanabil Investments With Participation From stc CIF & Vision Ventures to Redefine the Future of Payments
22:15 HKT/SGT
「同一屋檐下:岭南传统建筑源流与艺术」展览开幕
21:57 HKT/SGT
「同一屋簷下:嶺南傳統建築源流與藝術」展覽開幕
21:56 HKT/SGT
天韵国际(6836.HK)与临沂发展成立合资企业
19:32 HKT/SGT
天韵國際(6836.HK)與臨沂發展成立合資企業
19:31 HKT/SGT
Tianyun International (6836.HK) To Establish a joint venture with Linyi Development
19:30 HKT/SGT
Culture Capital Has Made Its Debut on the NASDAQ Tower Billboard with the Launch of Its Services in Asia
18:30 HKT/SGT
得到個人貸款的5個好處
17:00 HKT/SGT
5 Benefits of Getting a Personal Loan
17:00 HKT/SGT
Hitachi High-Tech Launches the GT2000 High-Precision Electron Beam Metrology System
16:23 HKT/SGT
DNA Plc Automates New Data Centers with Juniper Networks and NEC
15:34 HKT/SGT
A Beginner's Guide to Citibank Home Loan
15:00 HKT/SGT
The 4th PropertyGuru Asia Property Awards (India) recognise the nation's finest real estate companies
14:49 HKT/SGT
TOYOTA GAZOO Racing Presents new-look cars for WRC and WEC in 2024
13:51 HKT/SGT
Japan's finest alpine real estate rises at the 2023 PropertyGuru Asia Property Awards (Greater Niseko)
11:34 HKT/SGT
第五屆“金中環”榜單出爐!永豐金證券(亞洲)獲頒“財富管理最佳表現獎”及“最具綜合實力獎”
11:10 HKT/SGT
康沣生物心脏冷冻消融系统获NMPA批准上市
10:53 HKT/SGT
康灃生物心臟冷凍消融系統獲NMPA批准上市
10:52 HKT/SGT
Cryofocus Medtech Obtains NMPA Approval for the AF Cryoablation System
10:50 HKT/SGT
Novationwire推出专为马来西亚定制的人工智能品牌传播服务
10:13 HKT/SGT
Novationwire推出專為馬來西亞定制的人工智慧品牌傳播服務
10:12 HKT/SGT
Novationwire Debuts Malay AI-Branding-Leverage Offering Targeting Malaysia
10:00 HKT/SGT
Novationwire Debuts Malay AI-Branding-Leverage Offering Targeting Malaysia
09:00 HKT/SGT
同時花錢和賺錢,花旗Plus信用卡讓您輕鬆體驗
07:00 HKT/SGT
Spend and Earn at the Same Time with Citi Plus Credit Card
07:00 HKT/SGT
Monday, December 11, 2023
Rover Metals Prepares Cabin Lake Gold Project For Sale
22:30 HKT/SGT
Moderna公司回顧了在第二次環境、社會和治理(ESG)投資者活動中取得的進展和雄心
20:00 HKT/SGT
Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event
20:00 HKT/SGT
兼顾企业发展及社会责任 联控走出良性发展路径
17:17 HKT/SGT
兼顧企業發展及社會責任 聯控走出良性發展路徑
17:16 HKT/SGT
Real estate exemplars succeed at the 18th PropertyGuru Asia Property Awards Grand Final
17:07 HKT/SGT
Landmark 10th edition of the PropertyGuru Asia Property Awards (Mainland China, Hong Kong, Macau) elevates preeminent developers, designers
16:18 HKT/SGT
5 Ideas on How to Manage Your Personal Loan in Singapore Effectively
16:00 HKT/SGT
life@KCC「圣诞『冰』团」城市出没注意 圣诞老人率领一众萌萌动物 出城大派圣诞礼物
14:39 HKT/SGT
life@KCC「聖誕『冰』團」城市出沒注意 聖誕老人率領一眾萌萌動物 出城大派聖誕禮物
14:38 HKT/SGT
Fujitsu chosen for Dow Jones Sustainability World Index for 22nd time
14:19 HKT/SGT
助力金融高水平开放 中国上市公司协会举办香港投资者交流活动
14:06 HKT/SGT
中國上市公司協會舉辦香港投資者交流活動 吸引百餘家境外機構參會
14:05 HKT/SGT
富士通、「健康経営アライアンス」に参画
13:00 HKT/SGT
Online Video Remains the Growth Engine of Content Investment with Local Content Still Key to Acquiring Subscribers
11:42 HKT/SGT
Olympus Named to Dow Jones Sustainability World Index for Three Consecutive Years
10:00 HKT/SGT
Eisai and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 LEAP-001 Trial Evaluating LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) as First-Line Treatment for Patients with Advanced or Recurrent Endometrial Carcinoma
09:28 HKT/SGT
Fujitsu joins Japan Health & Productivity Management Alliance
09:10 HKT/SGT
 ACN Search:
 
CITIC Telecom CPC Becomes New VMware Cloud Service Provider Pinnacle Tier Partner in the Broadcom Advantage Partner Program
 
Daily Newsletter
Browse Press Releases
Press Releases by Industry »
Press Releases by Language »
Multimedia Press Releases »
Events newsroom »
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575